BACKGROUND: NIN/RPN Binding protein 1 homologue (NOBp1), encoded by NOB1 gene, was reported to play an essential role in the oncogenesis and prognosis of carcinomas. We conducted a study to reveal its expression and clinical significance in breast infiltrating ductal carcinoma. METHODS: To explore the relationship between NOB1 expression and the clinical TNM (cTNM), 162 patients who undergone surgery were involved in the study. Compared to healthy tissues, abnormal localization and higher level of NOB1 in tumor cells was observed by Immunohistochemistry staining. Real-time PCR and western-blotting verified the up-regulation of NOB1 in carcinoma individuals. RESULTS: A significant correlation between high level of NOB1 and the T stage, lymph node metastasis and cTNM was shown. Furthermore, patients with higher level of NOB1 predicted a declined overall survival (OS). Notably, multivariate analyses by Cox's proportional hazard model revealed that expression of NOB1 was an independent prognostic factor in breast infiltrating ductal carcinoma. CONCLUSIONS: In summary, our present study clarify that the aberrant expression of NOB1 in breast infiltrating ductal carcinoma is possibly involved with tumorigenesis and development, and the NOB1 protein could act as a potential biomarker for prognosis assessment of breast infiltrating ductal carcinoma. Related mechanism is worthy of further investigation.
BACKGROUND: NIN/RPN Binding protein 1 homologue (NOBp1), encoded by NOB1 gene, was reported to play an essential role in the oncogenesis and prognosis of carcinomas. We conducted a study to reveal its expression and clinical significance in breast infiltrating ductal carcinoma. METHODS: To explore the relationship between NOB1 expression and the clinical TNM (cTNM), 162 patients who undergone surgery were involved in the study. Compared to healthy tissues, abnormal localization and higher level of NOB1 in tumor cells was observed by Immunohistochemistry staining. Real-time PCR and western-blotting verified the up-regulation of NOB1 in carcinoma individuals. RESULTS: A significant correlation between high level of NOB1 and the T stage, lymph node metastasis and cTNM was shown. Furthermore, patients with higher level of NOB1 predicted a declined overall survival (OS). Notably, multivariate analyses by Cox's proportional hazard model revealed that expression of NOB1 was an independent prognostic factor in breast infiltrating ductal carcinoma. CONCLUSIONS: In summary, our present study clarify that the aberrant expression of NOB1 in breast infiltrating ductal carcinoma is possibly involved with tumorigenesis and development, and the NOB1 protein could act as a potential biomarker for prognosis assessment of breast infiltrating ductal carcinoma. Related mechanism is worthy of further investigation.
Entities:
Keywords:
Breast cancer; NOB1 protein; immunohistochemistry; tissue microarray
Authors: Thomas Veith; Jan Philip Wurm; Elke Duchardt-Ferner; Benjamin Weis; Roman Martin; Charlotta Safferthal; Markus T Bohnsack; Enrico Schleiff; Jens Wöhnert Journal: Biomol NMR Assign Date: 2011-07-06 Impact factor: 0.746
Authors: Massimiliano Monticone; Emanuela Biollo; Andrea Fabiano; Marina Fabbi; Antonio Daga; Francesco Romeo; Massimo Maffei; Alice Melotti; Walter Giaretti; Giorgio Corte; Patrizio Castagnola Journal: Mol Cancer Res Date: 2009-10-27 Impact factor: 5.852
Authors: Nele Adriaenssens; Vincent Vinh-Hung; Geertje Miedema; Harijati Versmessen; Jan Lamote; Marian Vanhoeij; Pierre Lievens; Hilde van Parijs; Guy Storme; Mia Voordeckers; Mark De Ridder Journal: Breast Cancer (Auckl) Date: 2012-07-30